USPTO serial 79127642
AGILIA
Reviewed by CopyMark Law Group
Reg. 4489989Status 706Registered
- Filing date
- Status date
- Registration date
- Mar 4, 2014
- Examiner
- LEE, DOUGLAS
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with AGILIA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott D. Woldow
Scott D. Woldow Smith, Gambrell & Russell, LLP1055 Thomas Jefferson St. NW, Suite 400Washington, DC 20036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Programmable medical device for global and interactive management of mono and multi-channel infusion, namely, programmable volumetric medical infusion instrument [ and their administration sets comprising tubes, intravenous lines, medical clips, medical ports and medical racks for global and interactive management of mono and multi-channel infusion ] ; medical infusion data capture and processing systems, namely, medical infusion diagnostic instruments for data capture and data processing; multi-channel analyzing, programming and monitoring systems, namely, intravenous drug administration instruments consisting of infusion pumps, syringe pumps [ and parts therefor ] for use in medical care facilities, general wards, intensive care units, operating rooms and emergency rooms; medical appliances and instruments for intravenous drug administration, namely, syringe pumps, volumetric pumps [, disposable syringes, medical tubes, intravenous lines, medical clips, medical ports, medical clamps, and racks for holding both the concentrates of the intravenous drugs and the medical infusion appliances and instruments ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 17, 2025 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Jul 2, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 2, 2024 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Nov 2, 2024 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Oct 27, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 4, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Mar 4, 2023 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Jan 27, 2022 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jun 27, 2021 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| May 19, 2021 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| May 19, 2021 | INPC | INVALIDATION PROCESSED | — |
| May 17, 2021 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 17, 2020 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Sep 17, 2020 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Sep 9, 2020 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Mar 16, 2020 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Mar 16, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 26, 2020 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Mar 4, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 31, 2014 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 14, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 14, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 4, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 4, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 17, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 17, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 14, 2013 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 27, 2013 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 27, 2013 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 27, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 9, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 9, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 4, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 4, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 30, 2013 | ALIE | ASSIGNED TO LIE | — |
| Oct 29, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 19, 2013 | RFNP | REFUSAL PROCESSED BY IB | — |
| May 2, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 2, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 1, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 30, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 24, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 13, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 9, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 8, 2013 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 4, 2013 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |